Department of Neurology, Neurology/Neurosurgery Intensive Care Unit, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Neurosurgery. 2012 May;70(5):1215-8; discussion 1219. doi: 10.1227/NEU.0b013e3182417bc2.
Mannitol has traditionally been the mainstay of medical therapy for intracranial hypertension in patients with head injury. We previously demonstrated that mannitol reduces brain volume in patients with cerebral edema, although whether this occurs because of a reduction in brain water, blood volume, or both remains poorly understood.
To test the hypothesis that mannitol acts by lowering blood viscosity leading to reflex vasoconstriction and a fall in cerebral blood volume (CBV).
We used O positron emission tomography to study 6 patients with traumatic brain injuries requiring treatment for intracranial hypertension. Cerebral blood flow (CBF), CBV, and cerebral metabolic rate for oxygen (CMRO2) were measured before and 1 hour after administration of 1.0 g/kg 20% mannitol.
CBV rose from 4.1 ± 0.4 to 4.2 ± 0.2 mL/100 g (P = .3), while intracranial pressure fell from 21.5 ± 4.9 to 13.7 ± 5.1 mm Hg (P < .003) after mannitol. Blood pressure, PaCO2, oxygen content, CBF, and CMRO2 did not change.
A single bolus of 1 g/kg of 20% mannitol does not acutely lower CBV. Another mechanism, such as a reduction in brain water, may better explain mannitol's ability to lower intracranial pressure and reduce mass effect.
甘露醇一直是治疗颅脑损伤患者颅内高压的主要药物。我们之前的研究表明,甘露醇可减少脑水肿患者的脑容量,尽管其作用机制是降低脑含水量、血容量还是两者兼而有之,目前仍不清楚。
验证甘露醇通过降低血液黏度导致反射性血管收缩和脑血容量(CBV)下降来发挥作用的假说。
我们使用 O 正电子发射断层扫描研究了 6 例因颅内高压而需要治疗的创伤性脑损伤患者。在给予 1.0 g/kg 20%甘露醇 1 小时前后测量脑血流量(CBF)、CBV 和脑氧代谢率(CMRO2)。
甘露醇给药后 CBV 从 4.1 ± 0.4 升至 4.2 ± 0.2 mL/100 g(P =.3),而颅内压从 21.5 ± 4.9 降至 13.7 ± 5.1 mm Hg(P <.003)。血压、PaCO2、氧含量、CBF 和 CMRO2 均未改变。
1 g/kg 20%甘露醇单次推注不会使 CBV 立即下降。另一种机制,如脑水减少,可能更好地解释甘露醇降低颅内压和减轻占位效应的能力。